Category: Media

Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

FemCerv®: Well-designed technology that can minimize patient discomfort

The Post-Roe Fertility Journey

US biomedical company launches intrauterine device for tubal evaluation

Femasys Targets Male Infertility with Updated Trial Design

Femasys Inc. Provides Strategic Update on its FemaSeed® Pivotal Trial Design to Expedite Clinical Program Advancement

Femasys Inc. Announces the Appointment of Christine Thomas as Senior Vice President of Regulatory and Clinical Affairs

Femasys Inc. Announces Enrollment Completion for Stage 2 Study of FemBloc for Permanent Birth Control

Femasys Inc. Announces the Commercial Availability of FemCerv® for Cervical Cancer Screening and Expands Management Team